Durlip® Liposomal Astaxanthin Oil is specifically designed for oil‑based dosage forms such as softgels. Sourced from Haematococcus pluvialis, it employs liposome encapsulation technology to wrap astaxanthin in phospholipid bilayers, achieving a relative bioavailability increase of 20.6 times and enabling active cellular uptake. This oil format offers a uniform and stable microstructure, excellent dispersibility in oil, clearly distinguishable quality, and a mild odor, facilitating smooth softgel filling. INNOBIO’s liposome technology overcomes traditional application limits of astaxanthin oil, delivering higher efficacy at the same dosage while improving product stability and consumer experience. Contact us for more information.
